Published in J Am Acad Child Adolesc Psychiatry on May 01, 2002
Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry (2007) 6.35
Biological processes in prevention and intervention: the promotion of self-regulation as a means of preventing school failure. Dev Psychopathol (2008) 2.93
The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry (2013) 2.48
The Food and Drug Administration's deliberations on antidepressant use in pediatric patients. Pediatrics (2005) 2.37
National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. J Am Acad Child Adolesc Psychiatry (2010) 1.84
Psychosocial treatment efficacy for disruptive behavior problems in very young children: a meta-analytic examination. J Am Acad Child Adolesc Psychiatry (2012) 1.73
Change what? Identifying quality improvement targets by investigating usual mental health care. Adm Policy Ment Health (2010) 1.52
A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol Neurobiol (2009) 1.45
Child/Adolescent anxiety multimodal study: evaluating safety. J Am Acad Child Adolesc Psychiatry (2014) 1.43
Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns? Psychiatr Serv (2010) 1.23
Trends in mental health and chronic condition visits by children presenting for care at U.S. emergency departments. Public Health Rep (2007) 1.22
Internet-delivered, family-based treatment for early-onset OCD: a preliminary case series. J Clin Child Adolesc Psychol (2013) 1.15
US suicide rates by age group, 1970-2002: an examination of recent trends. Am J Public Health (2006) 1.14
Psychostimulants and cognition: a continuum of behavioral and cognitive activation. Pharmacol Rev (2013) 1.13
Research in child and adolescent psychopharmacology: recent accomplishments and new challenges. Psychopharmacology (Berl) (2006) 1.07
Rationale and Considerations for the Internet-Based Delivery of Parent-Child Interaction Therapy. Cogn Behav Pract (2015) 1.06
ADHD medication use following FDA risk warnings. J Ment Health Policy Econ (2012) 1.04
Misuse of methamphetamine and prescription stimulants among youths and young adults in the community. Drug Alcohol Depend (2007) 1.04
Pediatric antidepressant use after the black-box warning. Health Aff (Millwood) (2009) 1.00
Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors. Future Neurol (2009) 0.98
A pilot feasibility evaluation of the CALM Program for anxiety disorders in early childhood. J Anxiety Disord (2011) 0.96
Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice. Neuropharmacology (2009) 0.92
Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands. Eur Child Adolesc Psychiatry (2009) 0.90
Adolescent experience of psychotropic treatment. Transcult Psychiatry (2009) 0.89
A critique of the international consensus statement on ADHD. Clin Child Fam Psychol Rev (2004) 0.89
National trends in psychotropic medication use in young children: 1994-2009. Pediatrics (2013) 0.88
Why most biomedical findings echoed by newspapers turn out to be false: the case of attention deficit hyperactivity disorder. PLoS One (2012) 0.88
The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states. J Child Adolesc Psychopharmacol (2014) 0.87
Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiol Drug Saf (2012) 0.84
Changes in adolescents mental health and use of alcohol and tobacco: a 10-year time-trend study of Finnish adolescents. Eur Child Adolesc Psychiatry (2012) 0.83
Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs. Front Psychiatry (2012) 0.83
Understanding the agreements and controversies surrounding childhood psychopharmacology. Child Adolesc Psychiatry Ment Health (2008) 0.83
Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008. Psychiatr Serv (2014) 0.81
Rates of psychotropic medication use over time among youth in child welfare/child protective services. J Child Adolesc Psychopharmacol (2010) 0.81
Pediatric psychotropic polypharmacy. Psychiatry (Edgmont) (2005) 0.80
Competent psychopharmacology. Can J Psychiatry (2014) 0.80
Methylphenidate and μ opioid receptor interactions: a pharmacological target for prevention of stimulant abuse. Neuropharmacology (2011) 0.79
Temporal patterns of medications dispensed to children and adolescents in a national insured population. PLoS One (2012) 0.79
Prescription of psychiatric medications and polypharmacy in the LAMS cohort. Psychiatr Serv (2013) 0.79
The role of parent characteristics in community-based medication treatment for children with disruptive behavior problems. Community Ment Health J (2012) 0.78
Chronic methylphenidate treatment during early life is associated with greater ethanol intake in socially isolated rats. Alcohol Clin Exp Res (2014) 0.78
Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents. J Child Adolesc Psychopharmacol (2014) 0.77
Use of Mental Health Services by Children Ages Six to 11 With Emotional or Behavioral Difficulties. Psychiatr Serv (2015) 0.77
The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children. PLoS One (2013) 0.77
Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychotics. J Child Adolesc Psychopharmacol (2015) 0.76
Impact of family structure on stimulant use among children with attention-deficit/hyperactivity disorder. Health Serv Res (2009) 0.76
Time trends in symptoms of mental illness in children and adolescents in Canada. CMAJ (2014) 0.76
Adiposity and Cardiometabolic Risk in Children With and Without Antipsychotic Drug Treatment. J Clin Endocrinol Metab (2015) 0.75
American parents' willingness to prescribe psychoactive drugs to children: a test of cultural mediators. Soc Psychiatry Psychiatr Epidemiol (2013) 0.75
Previous Out-of-Pocket Drug Expenditures and Patterns of Antidepressant Use among Workers Receiving Depression-Related Disability Benefits. Healthc Policy (2008) 0.75
Recent trends in primary-care antidepressant prescribing to children and young people: an e-cohort study. Psychol Med (2016) 0.75
Adverse effects of psychotropic medications in children: predictive factors. J Can Acad Child Adolesc Psychiatry (2014) 0.75
The FDA And ABCs: Unintended Consequences Of Antidepressant Warnings On Human Capital. J Hum Resour (2014) 0.75
Psychotropic medication characteristics for special education students with emotional and/or behavioral disorders. J Child Adolesc Psychopharmacol (2014) 0.75
Use of Psychotropic Medications among Youth in Treatment Foster Care. J Child Fam Stud (2014) 0.75
Building an evidence base in complementary and integrative healthcare for child and adolescent psychiatry. Child Adolesc Psychiatr Clin N Am (2013) 0.75
Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats. Behav Pharmacol (2014) 0.75
Antidepressant Use by Youth with Minimal or Mild Depression: Evidence from 3 Health Systems. Pediatr Qual Saf (2017) 0.75
Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data. J Korean Med Sci (2017) 0.75
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
National trends in the outpatient treatment of depression. JAMA (2002) 7.09
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
The most expensive medical conditions in America. Health Aff (Millwood) (2002) 5.50
National patterns in antidepressant medication treatment. Arch Gen Psychiatry (2009) 4.82
The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2006) 4.58
Screening for bipolar disorder in the community. J Clin Psychiatry (2003) 4.24
Trends in mental health care among children and adolescents. N Engl J Med (2015) 3.54
Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry (2006) 3.50
Trends in care by nonphysician clinicians in the United States. N Engl J Med (2003) 3.24
Retractions in the research literature: misconduct or mistakes? Med J Aust (2006) 3.17
National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry (2003) 3.07
A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry (2004) 3.00
Development and natural history of mood disorders. Biol Psychiatry (2002) 2.90
Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care (2011) 2.81
Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res (2013) 2.77
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry (2011) 2.58
Declining use of electroconvulsive therapy in United States general hospitals. Biol Psychiatry (2012) 2.50
Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. Am J Psychiatry (2008) 2.42
Applying theory-driven approaches to understanding and modifying clinicians' behavior: what do we know? Psychiatr Serv (2007) 2.41
Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry (2003) 2.40
Religiosity and major depression in adults at high risk: a ten-year prospective study. Am J Psychiatry (2011) 2.35
Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics (2008) 2.32
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry (2013) 2.30
Interventions for adolescent depression in primary care. Pediatrics (2006) 2.28
National trends in outpatient psychotherapy. Am J Psychiatry (2010) 2.24
Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry (2004) 2.24
Comparison of objective and patient-reported hot flash measures in men with prostate cancer. J Support Oncol (2009) 2.20
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry (2009) 2.13
Cortical thinning in persons at increased familial risk for major depression. Proc Natl Acad Sci U S A (2009) 2.04
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry (2007) 2.03
Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol (2003) 2.02
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry (2007) 1.98
Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study. Arch Gen Psychiatry (2006) 1.93
Improving recognition of adolescent depression in primary care. Arch Pediatr Adolesc Med (2006) 1.92
Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin Ther (2006) 1.92
Training and consultation to promote implementation of an empirically supported treatment: a randomized trial. Psychiatr Serv (2012) 1.87
Parental depression, child mental health problems, and health care utilization. Med Care (2003) 1.86
Change in child psychopathology with improvement in parental depression: a systematic review. J Am Acad Child Adolesc Psychiatry (2008) 1.83
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management. Pediatrics (2007) 1.82
Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy. Am J Psychiatry (2009) 1.82
National trends in hospitalization of youth with intentional self-inflicted injuries. Am J Psychiatry (2005) 1.80
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2011) 1.80
Adapting group interpersonal psychotherapy for a developing country: experience in rural Uganda. World Psychiatry (2003) 1.77
Decline in placebo-controlled trial results suggests new directions for comparative effectiveness research. Health Aff (Millwood) (2013) 1.76
Genetics of recurrent early-onset major depression (GenRED): final genome scan report. Am J Psychiatry (2007) 1.76
Hyperlipidemia following treatment with antipsychotic medications. Am J Psychiatry (2006) 1.74
Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Arch Gen Psychiatry (2008) 1.73
Screening for bipolar disorder in a primary care practice. JAMA (2005) 1.72
Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biol Psychiatry (2010) 1.70
Depression in US Hispanics: diagnostic and management considerations in family practice. J Am Board Fam Pract (2005) 1.69
Continuity of care after inpatient discharge of patients with schizophrenia in the Medicaid program: a retrospective longitudinal cohort analysis. J Clin Psychiatry (2010) 1.67
Adding or switching antipsychotic medications in treatment-refractory schizophrenia. Psychiatr Serv (2007) 1.67
Comparison of public attributions, attitudes, and stigma in regard to depression among children and adults. Psychiatr Serv (2007) 1.66
The organizational social context of mental health services and clinician attitudes toward evidence-based practice: a United States national study. Implement Sci (2012) 1.65
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review. J Am Acad Child Adolesc Psychiatry (2003) 1.63
Depression in African Americans: breaking barriers to detection and treatment. J Fam Pract (2006) 1.60
National trends in the use of outpatient psychotherapy. Am J Psychiatry (2002) 1.59
Children of currently depressed mothers: a STAR*D ancillary study. J Clin Psychiatry (2006) 1.57
Psychiatric opinion and antipsychotic selection in the management of schizophrenia. Psychiatr Serv (2008) 1.56
Public knowledge and assessment of child mental health problems: findings from the National Stigma Study-Children. J Am Acad Child Adolesc Psychiatry (2008) 1.53
Evidence-based practice for acute low back pain in primary care: patient outcomes and cost of care. Pain (2006) 1.52
Growth and decentralization of the medical literature: implications for evidence-based medicine. J Med Libr Assoc (2005) 1.50
Families at high and low risk for depression: a three-generation startle study. Biol Psychiatry (2005) 1.49
Barriers to the identification and management of psychosocial issues in children and maternal depression. Pediatrics (2007) 1.48
Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry (2002) 1.48
Tracking publication outcomes of National Institutes of Health grants. Am J Med (2005) 1.48
Family discord, parental depression, and psychopathology in offspring: ten-year follow-up. J Am Acad Child Adolesc Psychiatry (2002) 1.48
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry (2007) 1.48
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): I. Identification, assessment, and initial management. Pediatrics (2007) 1.48
Emergency treatment of young people following deliberate self-harm. Arch Gen Psychiatry (2005) 1.47
Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology (2008) 1.46
Social anxiety disorder in primary care. Gen Hosp Psychiatry (2005) 1.46
Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol (2003) 1.46
Observed classroom behavior of children with ADHD: relationship to gender and comorbidity. J Abnorm Child Psychol (2002) 1.45
Genetics of recurrent early-onset major depression (GenRED): significant linkage on chromosome 15q25-q26 after fine mapping with single nucleotide polymorphism markers. Am J Psychiatry (2007) 1.43
Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med (2005) 1.42
Public knowledge, beliefs, and treatment preferences concerning attention-deficit hyperactivity disorder. Psychiatr Serv (2007) 1.41
Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol (2005) 1.41
Characterizing Primary Care Visit Activities at Veterans Health Administration Clinics. J Healthc Manag (2015) 1.40
Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry (2005) 1.39
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Child Adolesc Psychiatry (2003) 1.39
The role of treatment fidelity on outcomes during a randomized field trial of an autism intervention. Autism (2013) 1.38
Trends in the inpatient mental health treatment of children and adolescents in US community hospitals between 1990 and 2000. Arch Gen Psychiatry (2007) 1.37
Disseminating child & adolescent mental health treatment methods: an international feasibility study. Rev Bras Psiquiatr (2006) 1.37
Medical services for clients in community mental health centers: results from a national survey. Psychiatr Serv (2008) 1.37
Training of evidence-based assessment and intervention approaches in cross-cultural contexts: challenges and solutions. Rev Bras Psiquiatr (2006) 1.36
Family discord, parental depression, and psychopathology in offspring: 20-year follow-up. J Am Acad Child Adolesc Psychiatry (2006) 1.34
Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry (2006) 1.34
Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am J Hum Genet (2004) 1.32
Development of adaptable and flexible treatment manuals for externalizing and internalizing disorders in children and adolescents. Rev Bras Psiquiatr (2006) 1.32
Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol (2010) 1.31
Reliability of the services for children and adolescents-parent interview. J Am Acad Child Adolesc Psychiatry (2004) 1.31